An add-on? Jesus please, it became the strategic priority of the company and most investors. In any event, an add-on to what? The disastrous FDA-blocked Ryoncil (sad for all)? A failed P3 trial for heart failure? A potentially failed back pain trial?
Rome is burning. I'm as upset about it as the next person, and have lost money, but at least I can look reality sqarely in the face.
Ann: Mesoblast Update on COVID-19 ARDS Trial, page-243
-
- There are more pages in this discussion • 833 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.030(2.52%) |
Mkt cap ! $1.370B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.15 | $4.226M | 3.581M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 10982 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 18383 | 9 |
View Market Depth
| Last trade - 13.37pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |